Guardian Pharmacy Services, Inc. Class A Common Stock (GRDN)
23.52
+0.20 (0.86%)
NYSE · Last Trade: Apr 16th, 8:44 PM EDT
Detailed Quote
Previous Close | 23.32 |
---|---|
Open | 23.31 |
Bid | 17.75 |
Ask | 37.20 |
Day's Range | 22.71 - 23.68 |
52 Week Range | 14.16 - 25.74 |
Volume | 67,048 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 114,043 |
Chart
News & Press Releases
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy services companies, and Mullaney’s Pharmacy, a Guardian Pharmacy member based in Cincinnati, today announced the opening of a new pharmacy in Columbus, Ohio. Operating as Guardian Pharmacy of Ohio, the new location – together with the Cincinnati pharmacy – will strengthen Guardian’s presence in the region and allow it to provide even better service to residents in assisted living, skilled nursing and behavioral health communities as well as individuals with intellectual and developmental disabilities across Ohio, northern and central Kentucky, and western West Virginia.
By Guardian Pharmacy Services, Inc. · Via Business Wire · April 14, 2025
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy services companies, and Guardian Pharmacy of Southwest Florida today announced the opening of a new pharmacy in Naples, Fla. This pharmacy, together with the North Port location, will allow Guardian Pharmacy of Southwest Florida to better serve residents in assisted living, skilled nursing and behavioral health communities, as well as individuals with intellectual and developmental disabilities across the region, stretching from Sarasota to Lake Placid to Marco Island.
By Guardian Pharmacy Services, Inc. · Via Business Wire · April 8, 2025
Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the fourth quarter and full year ended December 31, 2024.
By Guardian Pharmacy Services, Inc. · Via Business Wire · March 26, 2025

Guardian Pharmacy Services, Inc. (“Guardian” or the “Company”) (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.
By Guardian Pharmacy Services, Inc. · Via Business Wire · March 3, 2025

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Raymond James & Associates’ 46th Annual Institutional Investors Conference, being held in Orlando, on Monday, March 3, 2025, including a presentation at 9:50am ET. The live audio webcast of the presentation will be available online at https://investors.guardianpharmacy.com. A replay of the presentation will also be available shortly after the Conference’s completion via the same link and will remain available until the Q1 2025 earnings release.
By Guardian Pharmacy Services, Inc. · Via Business Wire · February 17, 2025

Guardian Pharmacy Services, (NYSE: GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian’s Mid-Atlantic footprint and marks its first venture into New Jersey.
By Guardian Pharmacy Services, Inc. · Via Business Wire · December 17, 2024

Via Benzinga · December 3, 2024

Via Benzinga · December 2, 2024

Via Benzinga · November 19, 2024

Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the third quarter ended September 30, 2024.
By Guardian Pharmacy Services, Inc. · Via Business Wire · November 12, 2024

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Stephens Annual Investment Conference, being held in Nashville, on Thursday, November 21, 2024, including a fireside chat at 9:00am CT. The live audio webcast of the fireside chat will be available online at https://investors.guardianpharmacy.com. A replay of the fireside chat will also be available shortly after the Conference’s completion via the same link and will remain available for approximately 60 days.
By Guardian Pharmacy Services, Inc. · Via Business Wire · October 31, 2024

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET.
By Guardian Pharmacy Services, Inc. · Via Business Wire · October 30, 2024

Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market.
Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group -- saw their stocks open for trading.
Via Talk Markets · October 20, 2024

Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
Via Talk Markets · September 29, 2024